The Anglo-Scandinavian Cardiac Outcomes Trial: Blood pressure-lowering limb (ASCOT-BPLA): effects in patients with type 2 diabetes
Main Authors: | Ostergren, J, Sever, P, Poulter, N, Dahlof, B, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, S, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, OBrien, E |
---|---|
Format: | Conference item |
Published: |
2006
|
Similar Items
-
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
by: Dahlöf, B, et al.
Published: (2005) -
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.
by: Sever, P, et al.
Published: (2001) -
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).
by: Sever, P, et al.
Published: (2005) -
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
by: Ostergren, J, et al.
Published: (2008) -
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
by: Sever, P, et al.
Published: (2004)